These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20687945)

  • 21. First evidence for digenic inheritance in hereditary colorectal cancer by mutations in the base excision repair genes.
    Morak M; Massdorf T; Sykora H; Kerscher M; Holinski-Feder E
    Eur J Cancer; 2011 May; 47(7):1046-55. PubMed ID: 21195604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of monoallelic MUTYH mutation among Egyptian patients with colorectal cancer.
    Elsaid A; Elshazli R; El-Tarapely F; Darwish H; Abdel-Malak C
    Fam Cancer; 2017 Jan; 16(1):83-90. PubMed ID: 27631816
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Germline mutations in APC and MUTYH are responsible for the majority of families with attenuated familial adenomatous polyposis.
    Nielsen M; Hes FJ; Nagengast FM; Weiss MM; Mathus-Vliegen EM; Morreau H; Breuning MH; Wijnen JT; Tops CM; Vasen HF
    Clin Genet; 2007 May; 71(5):427-33. PubMed ID: 17489848
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased MUTYH mutation frequency among Dutch families with breast cancer and colorectal cancer.
    Wasielewski M; Out AA; Vermeulen J; Nielsen M; van den Ouweland A; Tops CM; Wijnen JT; Vasen HF; Weiss MM; Klijn JG; Devilee P; Hes FJ; Schutte M
    Breast Cancer Res Treat; 2010 Dec; 124(3):635-41. PubMed ID: 20191381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. APC or MUTYH mutations account for the majority of clinically well-characterized families with FAP and AFAP phenotype and patients with more than 30 adenomas.
    Filipe B; Baltazar C; Albuquerque C; Fragoso S; Lage P; Vitoriano I; Mão de Ferro S; Claro I; Rodrigues P; Fidalgo P; Chaves P; Cravo M; Nobre Leitão C
    Clin Genet; 2009 Sep; 76(3):242-55. PubMed ID: 19793053
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MUTYH-associated polyposis: 70 of 71 patients with biallelic mutations present with an attenuated or atypical phenotype.
    Aretz S; Uhlhaas S; Goergens H; Siberg K; Vogel M; Pagenstecher C; Mangold E; Caspari R; Propping P; Friedl W
    Int J Cancer; 2006 Aug; 119(4):807-14. PubMed ID: 16557584
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of the c.1227_1228dup (p.Glu410GlyfsX43) mutation in Tunisian families affected with MUTYH-associated-polyposis.
    Abdelmaksoud-Dammak R; Miladi-Abdennadher I; Amouri A; Tahri N; Ayadi L; Khabir A; Frikha F; Gargouri A; Mokdad-Gargouri R
    Fam Cancer; 2012 Sep; 11(3):503-8. PubMed ID: 22744763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple colorectal adenomas syndrome: The role of MUTYH mutation and the polyps' number in clinical management and colorectal cancer risk.
    Negro S; Bao QR; Scarpa M; Scognamiglio F; Pucciarelli S; Remo A; Agostini M; D'Angelo E; Mammi I; Schiavi F; Rossi S; Zingone F; Ferrara F; Fantin A; Cristofori C; Guido E; Rizzotto ER; Intini R; Bergamo F; Fassan M; Salviati L; Urso EDL
    Dig Liver Dis; 2024 Jun; 56(6):1087-1094. PubMed ID: 38071180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue.
    van Puijenbroek M; Nielsen M; Tops CM; Halfwerk H; Vasen HF; Weiss MM; van Wezel T; Hes FJ; Morreau H
    Clin Cancer Res; 2008 Jan; 14(1):139-42. PubMed ID: 18172263
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Common colorectal cancer risk alleles contribute to the multiple colorectal adenoma phenotype, but do not influence colonic polyposis in FAP.
    Cheng TH; Gorman M; Martin L; Barclay E; Casey G; ; ; Saunders B; Thomas H; Clark S; Tomlinson I
    Eur J Hum Genet; 2015 Feb; 23(2):260-3. PubMed ID: 24801760
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The natural history of a combined defect in MSH6 and MUTYH in a HNPCC family.
    van Puijenbroek M; Nielsen M; Reinards TH; Weiss MM; Wagner A; Hendriks YM; Vasen HF; Tops CM; Wijnen J; van Wezel T; Hes FJ; Morreau H
    Fam Cancer; 2007; 6(1):43-51. PubMed ID: 17039270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation between mutations and mRNA expression of APC and MUTYH genes: new insight into hereditary colorectal polyposis predisposition.
    Aceto GM; Fantini F; De Iure S; Di Nicola M; Palka G; Valanzano R; Di Gregorio P; Stigliano V; Genuardi M; Battista P; Cama A; Curia MC
    J Exp Clin Cancer Res; 2015 Oct; 34():131. PubMed ID: 26511139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of MUTYH and MSH6 germline mutations in colorectal cancer patients.
    Giráldez MD; Balaguer F; Caldés T; Sanchez-de-Abajo A; Gómez-Fernández N; Ruiz-Ponte C; Muñoz J; Garre P; Gonzalo V; Moreira L; Ocaña T; Clofent J; Carracedo A; Andreu M; Jover R; Llor X; Castells A; Castellví-Bel S;
    Fam Cancer; 2009; 8(4):525-31. PubMed ID: 19685280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Homozygous germline mutation in MUTYH gene in familial adenomatous polyposis].
    Alvarez K; Fuente Mde L; Orellana P; Wielandt AM; Heine C; Suazo C; Kronberg U; Carvallo P; López-Köstner F
    Rev Med Chil; 2012 Nov; 140(11):1457-63. PubMed ID: 23677194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunohistochemistry is not an accurate first step towards the molecular diagnosis of MUTYH-associated polyposis.
    van der Post RS; Kets CM; Ligtenberg MJ; van Krieken JH; Hoogerbrugge N
    Virchows Arch; 2009 Jan; 454(1):25-9. PubMed ID: 19031083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline MYH mutations in a clinic-based series of Canadian multiple colorectal adenoma patients.
    Croitoru ME; Cleary SP; Berk T; Di Nicola N; Kopolovic I; Bapat B; Gallinger S
    J Surg Oncol; 2007 May; 95(6):499-506. PubMed ID: 17219385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Attenuated polyposis of the large bowel: a morphologic and molecular approach.
    de Leon MP; Pedroni M; Roncucci L; Domati F; Rossi G; Magnani G; Pezzi A; Fante R; Bonetti LR
    Fam Cancer; 2017 Apr; 16(2):211-220. PubMed ID: 27783336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of MYH mutation carriers in colorectal cancer: a multicenter, case-control, population-based study.
    Balaguer F; Castellví-Bel S; Castells A; Andreu M; Muñoz J; Gisbert JP; Llor X; Jover R; de Cid R; Gonzalo V; Bessa X; Xicola RM; Pons E; Alenda C; Payá A; Piqué JM;
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):379-87. PubMed ID: 17368238
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Alterations of the base excision repair gene MUTYH in sporadic colorectal cancer.
    Kuno T; Matsubara N; Tsuda S; Kobayashi M; Hamanaka M; Yamagishi D; Tsukamoto K; Yamano T; Noda M; Ikeuchi H; Kim S; Tamura K; Tomita N
    Oncol Rep; 2012 Aug; 28(2):473-80. PubMed ID: 22641385
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Frequency and phenotypic spectrum of germline mutations in POLE and seven other polymerase genes in 266 patients with colorectal adenomas and carcinomas.
    Spier I; Holzapfel S; Altmüller J; Zhao B; Horpaopan S; Vogt S; Chen S; Morak M; Raeder S; Kayser K; Stienen D; Adam R; Nürnberg P; Plotz G; Holinski-Feder E; Lifton RP; Thiele H; Hoffmann P; Steinke V; Aretz S
    Int J Cancer; 2015 Jul; 137(2):320-31. PubMed ID: 25529843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.